tirzepatide surmount-1 weight loss percent 72 weeks results SURMOUNT-2: confers about 15% in adults with obesity and diabetes Tirzepatide after intensive lifestyle intervention

The price for a months supply of tirzepatide can vary without insurance

If it has frozen, you must discard it

Zepbound : Weight management for adults and, since 2024, treatment for obstructive sleep apnea in obese adults

These adverse effects are typically mild to moderate and tend to decrease over time

Published Phase 2 data for retatrutide in obesity (PubMed ID 37351564) and type 2 diabetes (PubMed ID 37385275) reported dose-dependent reductions in body weight and glycated hemoglobin across 48 weeks

Your safety is our priorityevery pharmacy partner is carefully vetted to ensure full compliance with strict FDA standards